Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult patients with R/R CD19 positive B-cell ALL. The company also develops ALLO-501, an anti-CD19 allogeneic CAR T cell product candidate that is in Phase I clinical trial for the treatment of R/R non-Hodgkin lymphoma; and ALLO-501A, which is in Phase I/II clinical trial for the treatment R/R large B-cell lymphoma or transformed follicular lymphoma. In addition, it is developing ALLO-715, an allogeneic CAR T cell product candidate that is in a Phase I clinical trial for treating R/R multiple myeloma; ALLO-605, an allogeneic CAR T cell product candidate for the treatment of multiple myeloma; ALLO-647, an anti-CD52 monoclonal antibody; CD70 to treat renal cell cancer; ALLO-819, an allogeneic CAR T cell product candidates for the treatment of acute myeloid leukemia; and DLL3 for the treatment of small cell lung cancer and other aggressive neuroendocrine tumors. The company has license and collaboration agreements with Pfizer Inc.; Servier; Cellectis S.A.; and Notch Therapeutics Inc., as well as clinical trial collaboration agreement with SpringWorks Therapeutics, Inc. It also has a strategic collaboration agreement with The University of Texas MD Anderson Cancer Center for the preclinical and clinical investigation of allogeneic CAR T cell product candidates. The company was incorporated in 2017 and is headquartered in South San Francisco, California. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Allogene Therapeutics Inc..
Allogene Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Allogene Therapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Allogene Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Allogene Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Allogene Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Allogene Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Allogene Therapeutics Inc.- Key Facts
2.2 Allogene Therapeutics Inc.- Geographic Locations
2.3 Allogene Therapeutics Inc.- Subsidiaries and Affiliates
2.4 Allogene Therapeutics Inc.- Business Divisions
2.5 Allogene Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Allogene Therapeutics Inc. Strategic Analysis Review
3.1 Allogene Therapeutics Inc.- Key Strategies
3.2 Allogene Therapeutics Inc.- Company Outlook Statement
3.3 Allogene Therapeutics Inc.- SWOT Analysis
3.3.1 Allogene Therapeutics Inc.- Key Strengths
3.3.2 Allogene Therapeutics Inc.- Key Weaknesses
3.3.3 Allogene Therapeutics Inc.- Potential Opportunities
3.3.4 Allogene Therapeutics Inc.- Potential Threats
3.4 Allogene Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Allogene Therapeutics Inc.- Business Overview
4.2 Allogene Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Allogene Therapeutics Inc.- Key Products
5.2 Allogene Therapeutics Inc.- Key Service Areas
5.3 Allogene Therapeutics Inc.- Key Brands
6 Company Developments
6.1 Allogene Therapeutics Inc.- Company History
6.2 Allogene Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Allogene Therapeutics Inc.- Income Statements
7.2 Allogene Therapeutics Inc.- Balance Sheet
7.3 Allogene Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Allogene Therapeutics Inc.- Direct Competitors
8.2 Allogene Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 Allogene Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 Allogene Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
